Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the trial is to evaluate the safety of intravenous (iv) lacosamide delivered
in a single dose followed by 6.5 days of oral lacosamide treatment in subjects with
partial-onset seizures.